Trials / Completed
CompletedNCT00928408
PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 305 (actual)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicentre, descriptive observational study of adult patients with primary HPT receiving cinacalcet in clinical practice in a number of countries in Europe. Patients will be enrolled within 1 month of initiating cinacalcet treatment, and data will be collected prospectively for up to 1 year from initiation. Data will continue to be collected from patients discontinuing cinacalcet before the end of this period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cinacalcet |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2011-12-01
- Completion
- 2012-02-01
- First posted
- 2009-06-26
- Last updated
- 2018-08-01
- Results posted
- 2013-11-14
Source: ClinicalTrials.gov record NCT00928408. Inclusion in this directory is not an endorsement.